FindTrial
Sign In

D dimer as a marker to assess severity of covid 19 pneumonia

D dimer as a marker in assessing the severity of covid as implicated radiologically

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/034603
Enrollment
237
Registered
2021-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: J128- Other viral pneumonia

Interventions

None listed

Sponsors

Columbia Asia referral hospital yeshwantpur
Lead Sponsor
Dr Sreekumar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All inpatients admitted with Covid 19 pneumonia in Columbia asia referral hospital yeshwantpur

Exclusion criteria

Exclusion criteria: All hypercoagulable states excluded. Previous cases of pulmonary embolism, DVT,liver disease,renal disease,active somekrs,cardiac failure,connective tissue diseases,post op cases excluded.

Design outcomes

Primary

MeasureTime frame
To establish D dimer as an important predictor of severity of covid 19pneumoniaTimepoint: At admission,3 days,1 week,1 month—

Secondary

MeasureTime frame
A correlation between SpO2 and D dimer levels in covid positive patients.Timepoint: 12 months—

Countries

India

Contacts

Public ContactAbdul majeed

Columbia Asia referral hospital

abdul.m@columbiaindiahospitals.com09731019030

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026